Resmed (RMD) Payables (2010 - 2026)

Resmed's Payables history runs 17 years deep, the most recent figure standing at $533.2 million for Q1 2026.

• Quarterly Payables rose 129.38% year-over-year to $533.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $533.2 million (up 129.38% YoY) and the FY2025 annual result came in at $288.1 million, up 16.33% from the prior year.
• Payables was $533.2 million for Q1 2026 at Resmed, up from $510.3 million in the prior quarter.
• Across five years, Payables topped out at $533.2 million in Q1 2026 and bottomed at $160.7 million in Q2 2023.
• A 5-year average of $263.2 million and a median of $212.3 million in 2023 frame the typical range for Payables.
• Annual changes were most pronounced in 2023 — Payables fell 5.03% — and 2026, when it jumped 129.38%.
• Resmed's Payables stood at $205.9 million in 2022, then rose by 3.1% to $212.3 million in 2023, then climbed by 8.44% to $230.2 million in 2024, then soared by 121.66% to $510.3 million in 2025, then grew by 4.49% to $533.2 million in 2026.
• Business Quant data shows RMD's Payables at $533.2 million in Q1 2026, $510.3 million in Q4 2025, and $526.7 million in Q3 2025.